{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:34:29Z","timestamp":1794893669827,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":114,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cancer Center at Illinois and the Carle Cancer Center","award":["CST EP082021"],"award-info":[{"award-number":["CST EP082021"]}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["T32EB019944"],"award-info":[{"award-number":["T32EB019944"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["T32EB019944"],"award-info":[{"award-number":["T32EB019944"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["BC200206\/W81XWH-20-BCRP-EOHS"],"award-info":[{"award-number":["BC200206\/W81XWH-20-BCRP-EOHS"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["ILLU-698-924"],"award-info":[{"award-number":["ILLU-698-924"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Prairie Dragon Paddlers"},{"name":"Sylvia D. Stroup Scholarship"},{"name":"University Scholar Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"DOI":"10.1038\/s41523-026-00987-0","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:46:54Z","timestamp":1782560814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ACSS2-mediated metabolic-epigenetic crosstalk drives Fulvestrant resistance and represents a novel therapeutic target"],"prefix":"10.1038","volume":"12","author":[{"given":"Ay\u00e7a N.","family":"Mogol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Young","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Arredondo","family":"Eve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire P.","family":"Schane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debapriya","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Barnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda D.","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik R.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grosse-Perdekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Madak-Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"987_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA: A Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA: A Cancer J. Clin."},{"key":"987_CR2","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto, A. N. et al. Breast Cancer Statistics, 2022. CA: A Cancer J. Clin. 72, 524\u2013541 (2022).","journal-title":"CA: A Cancer J. Clin."},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2021","unstructured":"Weigelt, B., Peterse, J. L. & Veer, L. J. V. T. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5, 591\u2013602 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"987_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/joim.12084","volume":"274","author":"AJ Redig","year":"2013","unstructured":"Redig, A. J. & McAllister, S. S. Breast cancer as a systemic disease: a view of metastasis. J. Intern. Med. 274, 113\u2013126 (2013).","journal-title":"J. Intern. Med."},{"key":"987_CR5","unstructured":"Institute, N. C. Breast Cancer SEER 5-Year Relative Survival Rates, 2014\u20132020, https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=55&data_type=4&graph_type=5&compareBy=stage&chk_stage_104=104&chk_stage_105=105&chk_stage_106=106&chk_stage_107=107&series=9&sex=3&race=1&age_range=1&advopt_precision=1&advopt_show_ci=on&hdn_view=0#resultsRegion0."},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-031-11836-4_10","volume":"1390","author":"JM Patel","year":"2022","unstructured":"Patel, J. M. & Jeselsohn, R. M. Estrogen Receptor Alpha and ESR1 mutations in breast cancer. Adv. Exp. Med. Biol. 1390, 171\u2013194 (2022).","journal-title":"Adv. Exp. Med. Biol."},{"key":"987_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3677","volume":"16","author":"CL Smith","year":"2014","unstructured":"Smith, C. L., Santen, R. J., Komm, B. & Mirkin, S. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes. Breast Cancer Res. 16, 212 (2014).","journal-title":"Breast Cancer Res."},{"key":"987_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep45411","volume":"7","author":"Y Gong","year":"2017","unstructured":"Gong, Y., Liu, Y.-R., Ji, P., Hu, X. & Shao, Z.-M. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Sci. Rep. 7, 45411 (2017).","journal-title":"Sci. Rep."},{"key":"987_CR9","first-page":"2821","volume":"9","author":"B Rozeboom","year":"2019","unstructured":"Rozeboom, B., Dey, N. & De, P. ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future. Am. J. Cancer Res. 9, 2821\u20132831 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","volume":"37","author":"AB Hanker","year":"2020","unstructured":"Hanker, A. B., Sudhan, D. R. & Arteaga, C. L. Overcoming endocrine resistance in breast cancer. Cancer Cell 37, 496\u2013513 (2020).","journal-title":"Cancer Cell"},{"key":"987_CR11","doi-asserted-by":"publisher","first-page":"36252","DOI":"10.18632\/oncotarget.26363","volume":"9","author":"M Anurag","year":"2018","unstructured":"Anurag, M., Ellis, M. J. & Haricharan, S. DNA damage repair defects as a new class of endocrine treatment resistance driver. Oncotarget 9, 36252\u201336253 (2018).","journal-title":"Oncotarget"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1038\/s41388-022-02483-8","volume":"41","author":"A Harrod","year":"2022","unstructured":"Harrod, A. et al. Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. Oncogene 41, 4905\u20134915 (2022).","journal-title":"Oncogene"},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1002\/cam4.2453","volume":"8","author":"M He","year":"2019","unstructured":"He, M. et al. Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant. Cancer Med. 8, 6212\u20136220 (2019).","journal-title":"Cancer Med."},{"key":"987_CR14","first-page":"1579","volume":"38","author":"Y Koi","year":"2018","unstructured":"Koi, Y. et al. Impact of Visceral Metastasis on Efficacy of Fulvestrant in Patients with Hormone Receptor-positive Recurrent Breast Cancer. Anticancer Res 38, 1579\u20131584 (2018).","journal-title":"Anticancer Res"},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.3390\/cancers12092397","volume":"12","author":"EK Cotul","year":"2020","unstructured":"Cotul, E. K. et al. Combined targeting of estrogen receptor Alpha and Exportin 1 in metastatic breast cancers. Cancers 12, 2397 (2020).","journal-title":"Cancers"},{"key":"987_CR16","doi-asserted-by":"publisher","unstructured":"Mogol, A. N. et al. NAD+ metabolism generates a metabolic vulnerability in endocrine-resistant metastatic breast tumors in females. Endocrinology. 164 https:\/\/doi.org\/10.1210\/endocr\/bqad073 (2023).","DOI":"10.1210\/endocr\/bqad073"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.molcel.2017.04.026","volume":"66","author":"X Li","year":"2017","unstructured":"Li, X. et al. Nucleus-translocated ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy. Mol. Cell 66, 684\u2013697.e689 (2017).","journal-title":"Mol. Cell"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","volume":"159","author":"SA Comerford","year":"2014","unstructured":"Comerford, S. A. et al. Acetate dependence of tumors. Cell 159, 1591\u20131602 (2014).","journal-title":"Cell"},{"key":"987_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58322-3","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. ACSS2 mediates an epigenetic pathway to regulate \u03b2-cell adaptation during gestation in mice. Nat. Commun. 16, 4697 (2025).","journal-title":"Nat. Commun."},{"key":"987_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11960","volume":"7","author":"X Gao","year":"2016","unstructured":"Gao, X. et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat. Commun. 7, 11960 (2016).","journal-title":"Nat. Commun."},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"101158","DOI":"10.1016\/j.drup.2024.101158","volume":"77","author":"D Gao","year":"2024","unstructured":"Gao, D. et al. Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation. Drug Resist. Updates 77, 101158 (2024).","journal-title":"Drug Resist. Updates"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen, K. P. et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat. Cancer 3, 232\u2013250 (2022).","journal-title":"Nat. Cancer"},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1541-7786.MCR-21-0781","volume":"20","author":"Q Zuo","year":"2022","unstructured":"Zuo, Q. et al. Targeting metabolic adaptations in the breast cancer-liver metastatic niche using dietary approaches to improve endocrine therapy efficacy. Mol. Cancer Res. 20, 923\u2013937 (2022).","journal-title":"Mol. Cancer Res."},{"key":"987_CR24","doi-asserted-by":"crossref","unstructured":"Zuo, Q. et al. Targeting metabolic adaptations in the breast cancer\u2013liver metastatic niche using dietary approaches to improve endocrine therapy efficacy. bioRxiv, 2021.2009.2007.458711 (2021).","DOI":"10.1101\/2021.09.07.458711"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2014.12.002","volume":"27","author":"ZT Schug","year":"2015","unstructured":"Schug, Z. T. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57\u201371 (2015).","journal-title":"Cancer Cell"},{"key":"987_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/0008-5472.CAN-20-1847","volume":"81","author":"KD Miller","year":"2021","unstructured":"Miller, K. D. et al. Targeting ACSS2 with a transition-state mimetic inhibits triple-negative breast cancer growth. Cancer Res 81, 1252\u20131264 (2021).","journal-title":"Cancer Res"},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","volume":"33","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Acetyl-CoA Synthetase 2: a critical linkage in obesity-induced Tumorigenesis in Myeloma. Cell Metab. 33, 78\u201393.e77 (2021).","journal-title":"Cell Metab."},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2049-3002-2-23","volume":"2","author":"JJ Kamphorst","year":"2014","unstructured":"Kamphorst, J. J., Chung, M. K., Fan, J. & Rabinowitz, J. D. Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate. Cancer Metab. 2, 23 (2014).","journal-title":"Cancer Metab."},{"key":"987_CR29","doi-asserted-by":"publisher","unstructured":"Sahuri-Arisoylu, M. et al. Acetate Induces Growth Arrest in Colon Cancer Cells Through Modulation of Mitochondrial Function. Front. Nutr. 8. https:\/\/doi.org\/10.3389\/fnut.2021.588466","DOI":"10.3389\/fnut.2021.588466"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41418-024-01262-0","volume":"31","author":"N Chen","year":"2024","unstructured":"Chen, N. et al. ACSS2 controls PPAR\u03b3 activity homeostasis to potentiate adipose-tissue plasticity. Cell Death Differ. 31, 479\u2013496 (2024).","journal-title":"Cell Death Differ."},{"key":"987_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s42003-020-0898-0","volume":"3","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Acetylation of histone H3K27 signals the transcriptional elongation for estrogen receptor alpha. Commun. Biol. 3, 165 (2020).","journal-title":"Commun. Biol."},{"key":"987_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez, L., Zhang, Y., Nakata, Y., Chan, H. L. & Morey, L. Epigenetic mechanisms in breast cancer therapy and resistance. Nat. Commun. 12, 1786 (2021).","journal-title":"Nat. Commun."},{"key":"987_CR33","doi-asserted-by":"publisher","unstructured":"Udden, S. N. et al. Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibition. JCI Insight 7, https:\/\/doi.org\/10.1172\/jci.insight.151851","DOI":"10.1172\/jci.insight.151851"},{"key":"987_CR34","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/ng.2822","volume":"45","author":"W Toy","year":"2013","unstructured":"Toy, W. et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat. Genet. 45, 1439\u20131445 (2013).","journal-title":"Nat. Genet."},{"key":"987_CR35","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"987_CR36","doi-asserted-by":"publisher","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","volume":"46","author":"DR Zerbino","year":"2018","unstructured":"Zerbino, D. R. et al. Ensembl 2018. Nucleic Acids Res. 46, D754\u2013D761 (2018).","journal-title":"Nucleic Acids Res."},{"key":"987_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"987_CR38","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108\u2013e108 (2013).","journal-title":"Nucleic Acids Res."},{"key":"987_CR39","doi-asserted-by":"publisher","unstructured":"Chen, Y., Chen, L., Lun, Aaron T. L., Baldoni, Pedro L. & Smyth, Gordon K. edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets. Nucleic Acids Res. 53 https:\/\/doi.org\/10.1093\/nar\/gkaf018 (2025).","DOI":"10.1093\/nar\/gkaf018"},{"key":"987_CR40","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47\u2013e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"987_CR41","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1214\/16-AOAS920","volume":"10","author":"B Phipson","year":"2016","unstructured":"Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann. Appl. Stat. 10, 946\u2013963 (2016).","journal-title":"Ann. Appl. Stat."},{"key":"987_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/wics.147","volume":"3","author":"H Wickham","year":"2011","unstructured":"Wickham, H. ggplot2. Wiley Interdiscip. Rev.: Comput. Stat. 3, 180\u2013185 (2011).","journal-title":"Wiley Interdiscip. Rev.: Comput. Stat."},{"key":"987_CR43","doi-asserted-by":"crossref","unstructured":"Ahlmann-Eltze, C. ggupset: Combination matrix axis for \u2018ggplot2\u2019to create \u2018UpSet\u2019plots. R package version 0.3. 0. DOI: https:\/\/CRAN.R-project.org\/package=ggupset (2020).","DOI":"10.32614\/CRAN.package.ggupset"},{"key":"987_CR44","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nprot.2018.015","volume":"13","author":"PJ Skene","year":"2018","unstructured":"Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006\u20131019 (2018).","journal-title":"Nat. Protoc."},{"key":"987_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00987-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:33:00Z","timestamp":1792362780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00987-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00987-0","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"136"}}